Use of a blood biomarker test improves economic utility in the evaluation of older patients presenting with cognitive impairment

Authors

William J Canestaro, University of Washington
Randall J Bateman, Washington University School of Medicine in St. Louis
David M Holtzman, Washington University School of Medicine in St. Louis
Mark Monane, C2N Diagnostics, LLC
Joel B Braunstein, C2N Diagnostics, LLC

Journal

Population Health Management

Publication Date

6-1-2024

Volume

27

Issue

3

First Page

174

Last Page

184

Document Type

Open Access Publication

DOI

10.1089/pop.2023.0309

Rights and Permissions

Canestaro WJ, Bateman RJ, Holtzman DM, Monane M, Braunstein JB. Use of a Blood Biomarker Test Improves Economic Utility in the Evaluation of Older Patients Presenting with Cognitive Impairment. Popul Health Manag. 2024 Jun;27(3):174-184. doi: 10.1089/pop.2023.0309. This Open Access article is distributed under the terms of the Creative Commons License [CC-BY] (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Recommended Citation

Canestaro, William J; Bateman, Randall J; Holtzman, David M; Monane, Mark; and Braunstein, Joel B, "Use of a blood biomarker test improves economic utility in the evaluation of older patients presenting with cognitive impairment." Population Health Management. 27, 3. 174 - 184. (2024).
https://digitalcommons.wustl.edu/oa_4/4565

Department

ICTS (Institute of Clinical and Translational Sciences)